BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 6127402)

  • 21. Uncoupling of the beta-adrenergic receptor as a mechanism of in vitro neutrophil desensitization.
    Galant SP; Britt S
    J Lab Clin Med; 1984 Feb; 103(2):322-32. PubMed ID: 6319518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related alterations in the catecholamine-sensitive adenylate cyclase system of the prostate.
    Shima S; Akamatsu N; Hirai M; Kouyama H
    Mol Pharmacol; 1985 Feb; 27(2):218-22. PubMed ID: 2982088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased beta-adrenergic responsiveness during senescence.
    Scarpace PJ
    Fed Proc; 1986 Jan; 45(1):51-4. PubMed ID: 3000835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney.
    Pracyk JB; Slotkin TA
    J Dev Physiol; 1991 Oct; 16(4):251-61. PubMed ID: 1667405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norepinephrine and BRL 37344 stimulate adenylate cyclase by different receptors in rat brown adipose tissue.
    Granneman JG
    J Pharmacol Exp Ther; 1990 Aug; 254(2):508-13. PubMed ID: 1974640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-adrenergic agonist-mediated desensitization in senescent rats.
    Scarpace PJ; Abrass IB
    Mech Ageing Dev; 1986 Aug; 35(3):255-64. PubMed ID: 2877123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo desensitization of the beta, but not the alpha 2-adrenoreceptor-coupled-adenylate cyclase system in hamster white adipocytes after administration of epinephrine.
    Pecquery R; Leneveu MC; Giudicelli Y
    Endocrinology; 1984 May; 114(5):1576-83. PubMed ID: 6325124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some characteristics of the beta-adrenergic system in rat adipocyte membranes after the chronic administrations of isoproterenol.
    Izawa T; Komabayashi T; Suda K; Kunisada Y; Shinoda S; Tsuboi M
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):253-6. PubMed ID: 2839878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G; Bottari S; Strosberg AD
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological maturation and beta-adrenergic effectors: pre- and postnatal development of the adenylate cyclase system in the rabbit heart.
    Schumacher WA; Sheppard JR; Mirkin BL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):587-93. PubMed ID: 6292391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of beta-adrenergic stimulated adenylate cyclase in turkey erythrocytes.
    Hoffman BB; Mullikin-Kilpatrick D; Lefkowitz RJ
    J Cyclic Nucleotide Res; 1979 Oct; 5(5):355-66. PubMed ID: 230209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
    Stickle D; Barber R
    Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanisms of desensitization of beta-adrenergic receptors].
    Cros G
    Bull Eur Physiopathol Respir; 1985; 21(5):35s-43s. PubMed ID: 2865991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging.
    Dax EM; Partilla JS; PiƱeyro MA; Gregerman RI
    Endocrinology; 1987 Apr; 120(4):1534-41. PubMed ID: 3030705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased beta-adrenergic agonist affinity and adenylate cyclase activity in senescent rat lung.
    Scarpace PJ; Abrass IB
    J Gerontol; 1983 Mar; 38(2):143-7. PubMed ID: 6298302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to adenylyl cyclase in isolated adipocytes.
    Granneman JG
    J Pharmacol Exp Ther; 1992 May; 261(2):638-42. PubMed ID: 1349644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adenosine Ri agonist, phenylisopropyladenosine, reduces high affinity isoproterenol binding to the beta-adrenergic receptor of rat myocardial membranes.
    Romano FD; Fenton RA; Dobson JG
    Second Messengers Phosphoproteins; 1988; 12(1):29-43. PubMed ID: 2848121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist-promoted high affinity state of the beta-adrenergic receptor in human neutrophils: modulation by corticosteroids.
    Davies AO; Lefkowitz RJ
    J Clin Endocrinol Metab; 1981 Oct; 53(4):703-8. PubMed ID: 6116722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoids increase GTP-dependent adenylate cyclase activity in cultured fibroblasts.
    Johnson GS; Jaworski CJ
    Mol Pharmacol; 1983 May; 23(3):648-52. PubMed ID: 6306432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
    Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S
    Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.